Previous 10 | Next 10 |
COPENHAGEN, Denmark, June 07, 2022 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, announced today that it has entered into ...
Danish company Evaxion Biotech (EVAX) on Friday filed to sell up to $100M ordinary shares, including ordinary shares represented by American depositary shares. The company said that, generally, it intends to use net proceeds of any offering of securities for working capital and other general ...
Gainers: Cullinan Oncology (CGEM) +21%. Concert Pharmaceuticals (CNCE) +20%. Babylon Holdings BBLN +16%. Blue Water Vaccines (BWV) +14%. ViewRay (VRAY) +10%. Losers: Eargo (EAR) -24%. Senseonics (SENS) -14%. Ascendis Pharma (ASND) -11%. Evaxion Biotech...
Dutch Bros (BROS) -39% on Q1 earnings release. Eargo (EAR) -24%. Beyond Meat (BYND) -28% on Q1 earnings release. Evaxion Biotech (EVAX) -17% on Q1 earnings release. Senseonics Holdings (SENS) -12%. ironSource (IS) -11% on Q1 earnings rele...
Evaxion Biotech A/S (EVAX) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Corey Davis – LifeSci Advisors Lars Wegner – Chief Executive Officer Jesper Nyegaard Nissen – Interim Chief Financial Officer Conference Call Participants Kevin DeGeet...
Evaxion Biotech ADS press release (EVAX): Q1 GAAP EPS of -$0.25 beats by $0.08. As of March 31, 2022, cash and cash equivalents were $31.4 million as compared to $32.2 million as of December 31, 2021. Guidance: We expect our existing cash and cash equivalents will be sufficient to f...
Received regulatory clearance in Australia to initiate phase 2b trial of lead cancer therapy EVX-01 targeting melanoma Completed recruitment for Phase 1/2a clinical trial for EVX-02 with all patients receiving first dose Announced publication on personalized therapy with EVX-01 in...
Gainers: Biohaven Pharmaceutical (BHVN) +71%. AdaptHealth (AHCO) +31%. Evaxion Biotech (EVAX) +25%. Assertio (ASRT) +22%. Haemonetics (HAE) +16%. Losers: Bausch Health (BHC) -26%. GoodRx (GDRX) -24%. Akanda (AKAN) -21%. Novavax ...
Are you searching for good penny stocks to buy? In May 2022, that is more easily said than done. With the stock market down at the start of the week, sentiment is cautious ahead of Wednesday’s CPI data. In what is expected to be one of the most important economic reports of the y...
Biohaven Pharmaceutical BHVN +72% on Q1 results. Evaxion Biotech (EVAX) +54% announces successful production of personalized cancer immunotherapies in phase 1/2a clinical trial for EVX-02. Vroom VRM +36% on Q1 results. Vertex Energy VTNR +16% on Q1 results. ...
News, Short Squeeze, Breakout and More Instantly...
Evaxion Biotech A/S Company Name:
EVAX Stock Symbol:
NASDAQ Market:
COPENHAGEN, Denmark, May 10, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced that on May 7, 2024, it received a...
NEW YORK, NY / ACCESSWIRE / May 7, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Conference taking place Wednesday and Thursday, May 8-9, 2024. The presentation schedule is subject to change...
Significant Phase 2 clinical trial progress obtained with first patient finalizing EVX-01 vaccine dosing Favorable safety profile confirmed Trial on track for one-year clinical efficacy readout in Q3 2024 COPENHAGEN, Denmark, April 17, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S ...